Deep Medicine Acquisition... (DMAQ)

AI Score

Unlock

2.96

-5.43 (-64.72%)

At close: Jan 31, 2024, 9:00 PM

Deep Medicine Acquisition Income Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020
Period Ending	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	90K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	15K	15K	15K	15K	15K	15K	15K	15K	15K	15K	46K	n/a
Gross Profit	n/a	-15K	-15K	75K	-15K	-15K	-15K	-15K	-15K	-15K	-15K	-46K	n/a
Operating Income	-359.95K	-270.35K	-261.56K	-859.97K	645.77K	-1.84M	-515.66K	-179.4K	-152.6K	-93.77K	-31.5K	-105.39K	n/a
Interest Income	n/a	90.69K	n/a	n/a	n/a	552.16K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-359.95K	-270.35K	-261.56K	-668.45K	645.77K	-165.56K	-154.42K	-183.35K	-135.42K	-78.77K	-16.5K	-59.4K	n/a
Net Income	-359.95K	-270.35K	-261.56K	-657.6K	577.35K	401.61K	-24.01K	-174.66K	-135.42K	-78.77K	-16.5K	-59.4K	n/a
Selling & General & Admin	368.89K	327.15K	328.18K	549.21K	400.36K	717.72K	269.83K	177.03K	137.6K	78.77K	16.5K	59.4K	n/a
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	46.6K	33.88K	58.92K	200K	15K	15K	15K	n/a	15K	15K	n/a	n/a	n/a
Operating Expenses	415.49K	346.03K	372.1K	749.21K	400.36K	717.72K	269.83K	177.03K	137.6K	78.77K	16.5K	59.4K	n/a
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	12.63K	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	415.49K	361.03K	372.1K	764.21K	415.36K	717.72K	269.83K	177.03K	137.6K	78.77K	16.5K	59.4K	n/a
Income Tax Expense	n/a	n/a	110.53K	-10.85K	68.42K	-567.16K	-130.41K	-8.69K	-17.18K	-93.77K	-31.5K	-105.39K	n/a
Shares Outstanding (Basic)	4.36M	4.39M	4.61M	2.31M	15.39M	16.43M	16.43M	8.74M	12.35M	16.43M	16.43M	n/a	16.43M
Shares Outstanding (Diluted)	4.36M	4.39M	4.61M	2.31M	15.39M	16.43M	16.43M	8.74M	12.35M	16.43M	16.43M	n/a	16.43M
EPS (Basic)	-0.08	-0.06	-0.06	-0.28	0.04	0.02	-0.00	-0.02	-0.01	-0.00	-0.00	n/a	n/a
EPS (Diluted)	-0.08	-0.06	-0.06	-0.28	0.04	0.02	-0.00	-0.02	-0.01	-0.00	-0.00	n/a	n/a
EBITDA	n/a	n/a	-482.63K	2.09M	-1.48M	-717.72K	n/a	-170.72K	n/a	n/a	-16.5K	-59.4K	n/a
EBIT	n/a	n/a	n/a	-859.97K	n/a	-1.27M	-385.25K	-185.72K	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	-39.59K	-90.69K	-221.07K	1.42M	-2.12M	567.16K	130.41K	8.69K	17.18K	15K	15K	46K	52.75K